<DOC>
	<DOCNO>NCT01556646</DOCNO>
	<brief_summary>Hypothesis : Tolvaptan improve cognitive function , brain edema health-related quality life cirrhotic patient hyponatremia</brief_summary>
	<brief_title>Effect Tolvaptan Cognitive Function Cirrhosis</brief_title>
	<detailed_description>Baseline assessment include 1. battery eight cognitive test 2 . Health related quality life 3 . MRI head evaluate MR spectroscopy diffusion tensor image Patients give tolvaptan 15-30mg qd 14 day test repeat . During first 3 day tolvaptan administration , patient admit serum sodium drawn every 8 hour . 24 hr urine collection also perform . Between initiation end tolvaptan , patient see least every 3-5 day . Participation terminate case patient get transplant develop overt HE .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Hyponatremia</mesh_term>
	<mesh_term>Tolvaptan</mesh_term>
	<criteria>Cirrhosis diagnose liver biopsy radiological evidence nodular cirrhotic liver varix endoscopy laboratory feature ( platelet count &lt; 150,000 AST/ALT ratio &gt; 1 ) . History HE control lactulose and/or rifaximin Last HE episode &gt; 2 month prior enrollment &lt; 2 episode within 6 month Minimental status exam score â‰¥25 Serum sodium &lt; 130mg/dl within last 14 day day enrollment Availability caregiver Able undergo MR head Uncontrolled HE manifest MMSE &lt; 25 Alcohol abuse within 3 month Illicit drug use within 3 month Psychoactive drug use regularly schedule antidepressant methadone . Contraindication MR examination ( see attach MRI Safety Form ) Placement transjugular intrahepatic portosystemic shunt ( TIPS ) Creatinine Clearance less 10 ml/min undergoing hemodialysis HIV infection Use azole medication Pregnancy Current use tolvaptan , hypertonic saline medical therapy hyponatremia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Cirrhosis</keyword>
	<keyword>Hepatic Encephalopathy</keyword>
	<keyword>Hyponatremia</keyword>
	<keyword>Brain MRI</keyword>
	<keyword>Health-related quality life</keyword>
	<keyword>cognitive function</keyword>
</DOC>